2026-09-26 · 2026-09 / week-4
Deep Fission’s funding risk is real; a FISN short still fails 10/5
Deep Fission’s funding risk is real; a FISN short still fails 10/5
Summary: Deep Fission’s own June filing says cash after its IPO would not fund the operating plan for the next twelve months, and the planned pilot reactor still needs substantial outside capital.[1] That is real equity risk. But the late-Friday company rebuttal has not yet been tested by a regular session, the short seller’s model is not independently verified, and the observed low-to-recent-high band makes the short’s reference-only base flat with a 35% adverse stress. Reject / no trade.
Research timestamp: September 26, 2026, 16:44 Singapore time (08:44 UTC). The U.S. market is closed. Price reference: FISN at $6.49 after hours, September 25, 7:55 p.m. EDT. That observation preceded Deep Fission’s 8:52 p.m. EDT rebuttal by 57 minutes and is not an executable entry. Market-data providers disagree on the regular close and volume; one displayed quote was very wide.
Opportunity Ranking
| Rank | Candidate | Direction | Mispricing | Evidence Freshness | Catalyst Window | Positioning | 10/5 Status | Tradeability | Main Rejection Risk |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Deep Fission (FISN) | Short screen | The SEC says the pilot is not fully funded and runway is under 12 months; however, short-report allegations are not verified, the reply came after the last quote, and the stock is near a recent low | Sep. 25 company rebuttal; June SEC 10-Q and prospectus; Sep. 10 and Sep. 21 company technical updates; Sep. 25 secondary tape | Sep. 28 first regular session after the rebuttal; later commercial-scale borehole, DOE authorization and financing milestones are not dated | FINRA-derived Sep. 15 report: 1.247M shares short; vendor float and days-to-cover figures conflict; live locate/borrow unverified | Reject: reference base 0%; observed adverse marker +35.4%; 0:1 reward/adverse | Secondary snapshot showed a $1.89 displayed spread; depth, venue quality, exit size and borrow are unverified | A favorable technical or financing update can squeeze a thinly traded, pre-revenue reactor story; the company’s claims have not yet had a post-rebuttal session test |
| 2 | Fluence Energy (FLNC) | Short screen | Fiscal 2026 revenue guide fell to about $2.4B from a prior $3.0B midpoint, and adjusted EBITDA loss widened to about $200M from $10M; Friday shares rebounded 5.2% | Sep. 16 issuer revision; Sep. 25 market history | Fiscal 2026 results and fiscal 2027 plan; no fresh date in reviewed materials | Current short interest, borrow and ownership flows not verified | Reject: already repriced sharply; manufacturing recovery and backlog conversion can drive a large rebound | More liquid than FISN, but current quote/borrow gates not audited | The issuer attributes the reset to Houston contract-manufacturing delays and says output is improving; Friday’s rebound warns against treating the guide cut as one-way |
| 3 | Nucor (NUE) | Short screen | Q3 EPS guidance rose to $5.55–$5.65 per diluted share from Q2 adjusted EPS of $4.84, alongside higher steel prices and stable mill volumes | Sep. 17 issuer guidance | Q3 report scheduled Oct. 26 | No current direct positioning evidence reviewed | Reject: primary evidence is improving, not a short catalyst | Liquid listed common; no short execution audit | Nucor repurchased about 2.03M shares at an average $247.04 in Q3; its price and operating outlook can strengthen into results |
Selected opportunity: FISN, for information value only, not as the best executable short.
Why this one now: A public short report and the issuer’s response create a dated, observable disagreement. The most useful question is not whether the author or the company is “right” in the abstract. It is what primary evidence already establishes, which claims remain unverified, and whether the price after the next regular session offers any asymmetry. The latest $6.49 after-hours mark came 57 minutes before the company’s 8:52 p.m. EDT rebuttal.
What should surprise the reader: Deep Fission does not need the short report to establish its financing risk: its own June 10-Q says the IPO proceeds plus existing cash would not fund the operating plan for the next twelve months, and it says major pilot stages are not fully funded. But the DOE’s approval of a Nuclear Safety Design Agreement, a 100-foot canister installation/retrieval test, and a new drilling collaboration are real development evidence. None proves a licensed reactor, full-depth borehole or commercial economics; none can be dismissed as if no work has occurred.
Why This Is the Best Opportunity Right Now
FISN is the freshest short-side event among the three candidates. The market has a disclosed financing problem, a technical development story and a conflicted report/rebuttal sequence. The stock fell from $7.80 at the September 23 close to $6.27 in the September 25 secondary snapshot, a 19.6% two-session decline. That is observed price action, not proof that the report caused all of the move: its exact publication time, opening-price record and report-day quote are inconsistent across available sources. The company’s rebuttal arrived after the final regular session and after the latest after-hours mark reviewed.
FLNC offers a cleaner quantified guidance reset but is already down substantially since September 16 and rebounded 5.2% on September 25. Nucor is a useful liquid comparator, yet its own near-term guide is for higher EPS and the company repurchased stock around the current price. FISN therefore ranks first for information value, not for execution. The short’s capital story is plausible; its five-day payoff is not bounded.
Why This Can Move More Than 5% Soon
The next regular session, Monday, September 28, is the first chance to observe price acceptance after the company’s Friday-night rebuttal. A return toward the September 18 high of $8.79 would be a 35.4% rise from the $6.49 after-hours reference. The catalyst is the market’s interpretation of the report, issuer response and technical disclosures, not a known financing date. No funding round or regulator action is scheduled in the following week in the sources reviewed.
The next fundamental tests are more concrete but less immediate: the company must fund and execute a commercial-scale borehole, obtain DOE authorization for its pilot reactor, install and integrate a nuclear system at depth, and progress through further regulatory review. The June prospectus said commercial-scale borehole and reactor work required additional capital and that the DOE agreement itself provided oversight, not funding. The cheapest confirmation of the dilution thesis is a new filing or financing announcement that states the amount, price, terms, net proceeds and resulting share count. The cheapest disconfirmation is a funded, dated project plan with completed full-scale drilling and regulatory milestones, not another company slogan or short-report rebuttal.
10/5 Asymmetry Gate
This is a one-week, reference-only price-path sensitivity for the first five regular sessions after the September 25 rebuttal, September 28–October 2. It is not a reactor valuation. Top uses the reported $6.10 52-week low; base holds at the $6.49 after-hours reference; bottom uses the reported $8.79 September 18 high. These are observed reference levels, not bounds on future prices. The source feeds disagree on September 25 price and volume, and no current order book or borrow terms are available.
| Test | Reference-only result from $6.49 after-hours mark |
|---|---|
| Favorable base-case move for short | 0.0% decline |
| Credible adverse observed-price stress | +35.4% underlying rise to $8.79 |
| Gross base reward / adverse risk | 0:1 |
| Probability-weighted reference price | $7.12; approximately −9.7% gross expected short return before costs |
| Classification | Reject / no trade |
The subjective 15%/55%/30% weights place limited weight on a further move to the recent low, the greatest weight on stabilization around the current reference, and meaningful weight on a reversion to the September 18 high if the report is discounted or the company’s development progress is credited. They are not observed frequencies. Even with these weights, the highest-probability base is flat, the observed squeeze marker is far beyond +5%, and base reward/adverse risk is zero. The negative weighted return is not a fair-value estimate. A terminal price above $8.79 remains possible.
Sensitivity: Keeping the same top and bottom but assigning 30% to $6.10, 50% to $6.49 and 20% to $8.79 gives a weighted price of $6.83, or about −5.3% gross for a short before borrow and spread. The base remains flat and the adverse move remains +35.4%; the classification stays Reject. Using a level below the observed 52-week low to force a 10% base decline would be an unsupported target, not underwriting.
What Should Surprise the Reader
The company’s June 30 cash balance was $93.0 million, not $93 thousand: the 10-Q’s financial tables are in thousands. It received $34.3 million net from its June IPO, yet management said existing cash plus that IPO and the February private placement would not fund the operating plan for the next twelve months. First-half operating cash use was $42.462 million.[1] A simple half-year average burn would imply about 13 months from $93 million, but that rough calculation omits planned pilot spending and is not management’s forecast; the filed conclusion is that more capital is needed.
The pilot is also not an imminent commercial reactor. The issuer’s September 10 test lowered and retrieved a 20-foot non-nuclear prototype canister at 100 feet in a 34-inch borehole. On September 21 it announced that it and Youngquist would jointly evaluate and test drilling methods; the company says the September 3 test and future full-depth drilling are distinct. The SEC prospectus says the next phases, including additional boreholes and the planned pilot reactor, were not fully funded. Deep Fission also reported DOE approval of a Nuclear Safety Design Agreement in August.[13] These details support a financing-risk case, while also documenting genuine progress that a short must price against.
The Setup
Fact: Deep Fission is a pre-revenue company developing a pressurized-water reactor for a proposed one-mile underground installation. In its June 10-Q it reported $93.016 million of cash and cash equivalents as of June 30, $42.462 million of operating cash use for the first half, and $52.353 million of first-half net loss. The same filing says its operating plan and available funds did not support the following twelve months without additional financing.
Fact: The June 18 prospectus said DOE participation did not provide direct funding, that the planned pilot reactor and later development stages were not fully funded, and that material additional capital would be required. It also said the company had updated previously identified milestones, including reactor criticality timing, to prioritize validating the most differentiated parts of the system. It targeted an NRC commercial-license application in the first half of 2027, subject to DOE authorization and further development.[2]
Issuer-reported progress: Deep Fission says DOE approved its Nuclear Safety Design Agreement. Its September 10 release describes a non-nuclear canister test at 100 feet, not a reactor test. Its September 21 release describes a collaboration to evaluate and test borehole methods, not a completed commercial-scale shaft or binding customer contract. The issuer's June release says its up-to-18.5 GW pipeline consists of non-binding LOIs without purchase, financing or deployment commitments.[14]
Report boundary: A secondary summary of Iceberg Research’s September 24 report describes a structural-cost and funding-gap thesis and says the report estimates a $289/MWh first-unit LCOE and roughly $350 million in unfunded needs. I could not retrieve the original report from its publisher during this run; the source returned HTTP 403. I therefore do not rely on those model outputs, its detailed comparisons or its account of past statements as verified facts. Deep Fission’s September 25 rebuttal calls the report misleading and says its author’s disclaimer discloses a financial interest in a lower share price; that is the issuer’s characterization, not an independent adjudication.
The Market Price
| Observation | Price / data | Timestamp / status |
|---|---|---|
| Regular-session close | $6.25 | Sep. 25, 2026, 4:00 p.m. EDT, StockAnalysis history |
| Latest after-hours reference | $6.49 | Sep. 25, 2026, 7:55 p.m. EDT, before the issuer rebuttal |
| Regular-session range / volume | $6.23–$6.75 / 573,120 | Sep. 25 StockAnalysis history; ChartExchange reported $6.27 close and 574,485 shares, while StockScan reported $6.485 close and 221,447 shares |
| Displayed bid / ask | $5.37 / $7.26; $1.89 spread | Same secondary snapshot; not verified NBBO, depth or executable capacity |
| Basic capitalization arithmetic | About $382M | $6.49 × 58.906M shares reported outstanding July 27; stale denominator, not fully diluted value |
The Sep. 25 7:55 p.m. after-hours quote precedes the issuer response at 8:52 p.m. EDT. The response has no observed regular-session acceptance yet. These market feeds disagree materially on last trade, volume and displayed quote. That uncertainty blocks a short entry; the article uses the $6.49 observation only as a labeled reference.
The Mispricing
The disagreement is between a public equity price near the reported 52-week low and an early-stage project that still needs capital, permitting, full-depth drilling and reactor integration. The short-side case is that investors may value a speculative pipeline and long-run electricity demand before the company proves its site-specific engineering and funds the pilot. The primary filing supports the capital dependency. It does not quantify a fair share price or establish that the company cannot raise funds.
The strongest bull case is also concrete. The issuer has moved beyond drawings: it drilled a data-acquisition well to 6,000 feet, completed a non-nuclear prototype canister emplacement/retrieval test, published a DOE-approved NSDA, and engaged an experienced driller to test larger-diameter borehole techniques. It reports that its proposed design combines established PWR technology with commercial drilling methods. If subsequent tests, DOE authorization, funding and a binding power customer arrive in sequence, the current share price could prove to understate option value. None of these milestones yet demonstrates criticality, nuclear integration at depth, NRC approval, binding PPAs or commercial economics.
The market’s implied probability of those outcomes is unknown. The two-day price decline cannot identify whether the marginal seller reacted to the short report, prior technical concerns, broader small-cap volatility or other factors. The most defensible conclusion is a real financing and commercialization risk, not a proven mispricing magnitude.
The Positioning
FINRA-settled data shown by a secondary tracker put FISN short interest at 1.247 million shares on September 15, up 31.8% from August 31. Against the SEC’s 58.906 million shares outstanding reported July 27, that is about 2.1% of total shares, not an official current free-float calculation. The tracker estimates 5.22 days to cover using a 239,016-share average-volume input; the statistic is stale relative to the report/rebuttal event and is not evidence of forced covering. It is a modest reported short position, not a crowded squeeze setup.[1][8]
A securities-lending aggregator citing IBKR data showed an indicative 12.46% annualized borrow fee and 15,000 shares available at 12:56 a.m. EDT on September 26.[9] Those are vendor snapshots, not a live locate, fee commitment or recall guarantee from a broker. At the displayed $1.89 spread and conflicting volume records,[7] neither modest reported short interest nor a short-report headline establishes a tradeable squeeze or a reliable exit.
The Catalyst
| Step | Timing / status | Observable test |
|---|---|---|
| First session after company rebuttal | Monday, Sep. 28; rebuttal issued Friday Sep. 25 at 8:52 p.m. EDT | Check regular-session price acceptance, consolidated range, volume, spread, depth and whether the issuer adds claim-by-claim evidence |
| Full-depth commercial-scale borehole | No dated completion schedule in the sources reviewed; prospectus says work continues over coming months | Verify drilling depth, diameter, geology, casing, cost, completion and third-party documentation; separate from a 100-foot canister demonstration |
| DOE pilot authorization and integrated demonstration | Conditional on engineering development, regulatory review and funding | Verify dated DOE authorization, construction, nuclear-system installation at depth, commissioning and testing milestones |
| Capital and share count | Next filing or financing announcement; exact timing unknown | Reconcile unrestricted cash, monthly operating use, committed pilot costs, financing proceeds, price, terms, warrants and fully diluted shares |
| Commercial terms | No binding PPA identified in the filing reviewed; company pipeline includes non-binding LOIs | Require an executed agreement, identifiable counterparty, volume, price, term, conditions, security and financing implications |
The cheapest falsification test for an “immediate dilution” short is a funded project plan with fresh cash, committed financing and a reconciled share count. The cheapest confirmation is a filed financing or engineering update that shows a larger-than-expected capital need, a failed drilling objective or another schedule reset. Neither observation alone would authorize a short without fresh borrow and market-structure checks.
The Payoff
The map below tests only a one-week event window after the September 25 rebuttal. It uses observed price markers, not a value for a nuclear company. Top is the reported 52-week low; base is the latest after-hours reference; bottom is the September 18 high. The 15%/55%/30% probabilities are subjective screening weights: modest odds of retesting the low, greatest weight on stabilization around the current reference, and material weight on reversion to the September 18 high as buyers credit technical progress or reject the report. They are not calibrated frequencies and do not cover a full upside gap.
Price Target and Probability Map
| Scenario | Probability | Target / Level | Return / Payoff | Horizon | Conditions | Evidence Quality |
|---|---|---|---|---|---|---|
| Top Case (best for short) | 15% | $6.10 | +6.0% gross short | Sep. 28–Oct. 2, reference-only | Revisit the reported 52-week low after regular-session acceptance fails to hold the current reference | Low: historical price marker, no valuation derivation |
| Base Case (highest probability) | 55% | $6.49 | 0.0% gross short | Same five-session window | Price stabilizes as the market weighs a short report and company rebuttal without a new financing or project milestone | Low: subjective assessment; latest quote predates the rebuttal |
| Bottom Case (worst for short) | 30% | $8.79 | −35.4% gross short | Same five-session window | Price reverts to the Sep. 18 high as buyers credit the demonstration and dismiss unverified report claims | Low: prior high, not an upside ceiling |
| Invalidation | n/a | No price stop | N/A | At new financing, DOE authorization or material technical disclosure | Re-underwrite when funding, commercial-scale borehole results or binding commercial terms materially alter the evidence; this is not an automatic entry | Medium |
Probability-weighted expected value: $7.12 (0.15×$6.10 + 0.55×$6.49 + 0.30×$8.79), about −9.7% gross for a short from $6.49 before spread, slippage, borrow and carry.
Current market level and timestamp: $6.49 after-hours reference, Sep. 25, 2026, 7:55 p.m. EDT; pre-rebuttal observation.
Primary instrument: Common stock only as a research reference; no expression is approved.
10/5 favorable base move: 0.0% decline.
10/5 credible adverse move: +35.4% underlying rise to the observed $8.79 reference; upside is not bounded there.
10/5 gross reward/adverse risk: 0:1.
10/5 measurement basis: Reference-only; not a verified entry.
10/5 status: Reject.
Confidence: High that the issuer disclosed a cash shortfall against its plan and that the Sep. 10 demo was non-nuclear at 100 feet; low on fair value, report allegations, short positioning and future price path.
The Kill Shot
The strongest bull case is that the short report’s central doubts about drilling and reactor integration may be overtaken by evidence: the company has completed a prototype canister demonstration with commercial equipment, DOE approved a safety-design agreement, and Youngquist brings an established large-borehole drilling business. The prospectus does not hide that it needs capital or that milestones moved; the stock is already far below its $16 IPO price and near its reported 52-week low. A financing round or successful commercial-scale borehole could cause a sharp re-rating.
The load-bearing short assumption is that future project capital cannot be raised at a price that preserves enough common-equity value. The SEC filing supports the existence of a funding need, but does not prove the amount, timing or terms of future dilution. The Iceberg report’s roughly $350 million funding-gap model is unavailable directly in this run; its detailed inputs are not independently verified. The thesis could be directionally right about long-run project economics while the short loses through a DOE milestone, a partner, a capital raise above expectations, concentrated buying in a thin market, borrow recall or a gap beyond the modeled high.
What Could Go Wrong
- The next session trades above $6.49 after the rebuttal, forcing shorts to cover into a wide market.
- DOE approval, a new drilling test or a financing package validates the path before the bearish capital model is priced.
- Investors treat the September demonstration as evidence of practical install/retrieval even though it was only 100 feet and non-nuclear; that narrative alone can move price.
- New shares dilute existing owners but fund the pilot and extend runway, creating a positive price reaction despite dilution.
- The stock gaps beyond $8.79, halts or becomes impossible to borrow; the observed price map is not a maximum-loss bound.
- The short seller’s model or company rebuttal proves inaccurate; both parties have incentives and the original report’s full methods were not inspected.
What Would Prove This Wrong
The financing-risk interpretation should be rebuilt if the company files committed capital sufficient to complete the pilot, identifies the amount and price of equity financing, and provides an auditable share count alongside an independently documented full-depth borehole and dated DOE authorization path. Stronger evidence would include nuclear-system installation at depth, commissioning progress, an enforceable PPA and a project-level cost model with a defined capital stack. These events would invalidate the assumption of an unresolved funding path; none automatically makes the stock a long.
Risk Audit
- Funding: company’s own 10-Q states proceeds plus cash do not fund the current plan for twelve months; pilot remains only partly funded.
- Technical: 100-foot non-nuclear canister demonstration does not validate a mile-deep reactor; geology, borehole, casing, system integration, commissioning and operation remain.
- Regulatory: DOE safety agreement and reactor pilot participation are not operating authorization, NRC commercial licensing or permission to sell electricity.
- Commercial: 18.5 GW pipeline and site MOUs are not binding orders, PPAs, financed projects or cash.
- Positioning: official settlement data are delayed; vendor float, days-to-cover and borrow estimates conflict; no locate or recall terms verified.
- Market: wide displayed spread, inconsistent close/volume feeds and thin dollar volume create gap and exit risk.
- Report integrity: original Iceberg source returned HTTP 403 during research; allegations are treated as allegations, not facts. The issuer rebuttal is also not independent validation.
Best Trade Strategy
No trade. Do not short FISN from the $6.49 after-hours reference, and do not use the $16 IPO price, September 18 high or secondary report’s LCOE estimate as a price floor or target. Reopen only after the September 28 regular session establishes acceptance, a broker confirms locate/borrow/recall terms, and the market provides a current consolidated quote, spread, depth, venue, volume quality and realistic exit capacity. Then reconcile post-IPO cash use, current fully diluted shares, committed pilot capital and DOE/engineering milestones. A future short case would still need a credible base decline of at least 10%, an evidence-backed squeeze bound no higher than 5%, a 2:1 gross reward/adverse ratio and positive expected value after carry. No options, leverage, margin, market orders or price-floor logic.
Sources
- Deep Fission Q2 2026 Form 10-Q (SEC) — cash, burn, going-concern language, shares outstanding, IPO proceeds, material weaknesses and statement that project stages remain underfunded.
- Deep Fission June 2026 IPO prospectus (SEC Form 424B4) — updated development sequence, DOE agreement limitations, pilot funding, site work, assumptions and non-binding LOI boundary.
- Deep Fission’s Sep. 25 rebuttal — issuer characterization and its statement that the report disclaimer identifies a short interest; not an independent adjudication.
- Deep Fission’s Sep. 10 canister demonstration release — issuer reports a non-nuclear canister at 100 feet and identifies it as one step in a broader validation program.
- Deep Fission/Youngquist Sep. 21 collaboration release — scope is to evaluate and test drilling methods; the issuer distinguishes the 100-foot demonstration from full-depth drilling.
- DOE Reactor Pilot Program — DOE describes a program-level goal of at least three concepts reaching criticality by July 4, 2026; it is not a company-specific guarantee.
- FISN Sep. 25 quote and tape snapshot, ChartExchange quote and StockScan history — StockAnalysis shows the latest after-hours mark at 7:55 p.m. EDT; providers conflict on regular close, range and volume. ChartExchange also showed a wide displayed quote, not verified NBBO or depth.
- FISN short-interest summary — reports 1.247M shares short at Sep. 15 FINRA settlement and estimates 5.22 days to cover using its own volume input; these are delayed vendor displays, not live positioning. See FINRA’s reporting methodology.
- Indicative FISN borrow data — vendor page attributes its Sep. 26 12:56 a.m. EDT 12.46% annualized fee and 15,000 shares available to IBKR data; not a locate or quote.
- Iceberg Research report landing page and secondary report synopsis — original report was inaccessible (HTTP 403); only the synopsis was read, and model claims are not treated as verified.
- Fluence Sep. 16 revised FY2026 guidance and Sep. 25 price history — comparison candidate.
- Nucor Sep. 17 Q3 2026 guidance and Sep. 25 price history — comparison candidate.
- Deep Fission’s DOE NSDA announcement — issuer’s account of the design agreement; it is not operating authorization or a commercial license.
- Deep Fission’s June 24 pipeline release — states that the 18.5 GW opportunity consists of non-binding LOIs.
Research Quality Scorecard
| Criterion | Score | Evidence-based reason |
|---|---|---|
| Market disagreement | 4/5 | Financing risk is filed, while the company has fresh technical milestones and the short report’s central model is unverified |
| Evidence base | 4/5 | Fresh SEC and issuer evidence, DOE program source, plus a direct report-access limitation |
| Positioning and flows | 2/5 | FINRA-settled short shares available through a secondary source; float, intraday borrow and recall data missing |
| Catalyst path | 3/5 | Rebuttal has an immediate next-session test; deeper milestones lack firm dates and funding |
| Payoff architecture | 2/5 | Observed-level sensitivity is auditable but does not produce a 10% base decline or bound the squeeze |
| Invalidation discipline | 4/5 | Funding, deep borehole, DOE authorization and binding power arrangements provide observable re-underwriting triggers |
| Differentiated insight | 4/5 | Separates a safety-design agreement, non-nuclear 100-foot test, deep borehole, pilot authorization and commercial license |
| Client value | 4/5 | Shows why real capital risk and a prominent short report still do not create a tradeable short after a large price decline |
| Total | 27/40 | Reject/no-trade; failed 10/5 overrides the Watchlist-range score |
Bottom Line
Deep Fission’s capital need is not a short seller’s invention: its own filings say the pilot is not fully financed and planned operations need more capital within twelve months. The short report, however, is not a substitute for an independently verified cost model, and the issuer has logged tangible but limited development steps. At a $6.49 pre-rebuttal reference, the most-probable path in the short-window sensitivity is flat while the observed upside marker is 35.4%. Reject / no trade.
AI Illustration Prompt
Create a restrained editorial finance illustration for The Mispricing Desk: place a one-mile borehole cross-section beside a small 20-foot reactor canister stopping at a clearly labeled “100 FT / NON-NUCLEAR / TESTED FOR INSTALL & RETRIEVAL,” not at reactor depth. Above ground, show two separate documents: “DOE SAFETY DESIGN AGREEMENT” and “COMMERCIAL LICENSE / OPERATING AUTHORIZATION: NOT YET.” A cash ledger reads “JUNE 30 CASH $93.0M; H1 OCF USED $42.5M; COMPANY SAYS <12 MONTHS UNDER CURRENT PLAN; PILOT NOT FULLY FUNDED.” A market strip reads “SEP 25 CLOSE $6.25 → 7:55 PM AH $6.49 → 8:52 PM REBUTTAL (AFTER QUOTE),” with small labels “$6.10 RECENT LOW / $8.79 SEP 18 HIGH” and a wide bid/ask gap. Use warm paper, graphite, muted navy and amber; no nuclear mushroom cloud, no futuristic reactor imagery, no fabricated cost chart, no implied trade instruction. Add a subtle readable “The Mispricing Desk” watermark, wide 16:9 editorial composition.